Juan Li

Prof. Dr. Juan Li


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2025 in Ageing Research Reviews
Verified
Journal Article
Closed access
YDYan Duan
Yan Duan
LZLi-Juan Zhao
Li-Juan Zhao
YLYu-Ting Lu
Yu-Ting Lu
JLJuan Li
Juan Li
SLShunxiang Li
Shunxiang Li

1 March 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
YHYuting Huang
Yuting Huang
ZLZhaoxing Li
Zhaoxing Li
YMYuan Ma
Yuan Ma
QWQianqian Wu
Qianqian Wu
JKJianping Kong
Jianping Kong
JLJuan Li
Juan Li
COVID-19, caused by SARS-CoV-2, has emerged as the most destructive emerging infectious disease of the 21st century. Vaccination is an effective method to combat viral diseases. However, due to the constant mutation of the virus, new variants may weaken the efficacy of vaccines. In the current field of new coronavirus research, viral protease inhibitors have emerged as a highly regarded therapeutic strategy. Nevertheless, existing viral protease inhibitors do not fully meet the therapeutic needs. Therefore, this paper turned to traditional Chinese medicine to explore new active compounds. This study focused on 24 isolated compounds from Acorus calamus L. and identified 8 active components that exhibited significant inhibitory effects on SARS-CoV-2 PLpro. Among these, the compound 1R,5R,7S-guaiane-4R,10R-diol-6-one demonstrated the best inhibitory activity with IC50 values of 0.386 ± 0.118 μM. Additionally, menecubebane B and neo-acorane A exhibited inhibitory activity against both Mpro and PLpro proteases, indicating their potential as dual-target inhibitors. The molecular docking results confirmed the stable conformations of these compounds with the key targets and their good activity. ADMET and Lipinski’s rule analyses revealed that all the small molecule ligands possessed excellent oral absorption properties. This study provides an experimental foundation for the discovery of promising antiviral lead compounds.

6 April 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YLYuting Lu
Yuting Lu
YDYan Duan
Yan Duan
YDYuping Dai
Yuping Dai
XNXiaoting Ni
Xiaoting Ni
JLJuan Li
Juan Li
SLShunxiang Li
Shunxiang Li

8 December 2025 in Food & Function
Verified
Journal Article
Closed access
PDF file
CLChen-Hui Li
Chen-Hui Li
YHYan-Xia Huang
Yan-Xia Huang
YDYan Duan
Yan Duan
GLGuo-Ping Liu
Guo-Ping Liu
ZAZhi-Wei Ai
Zhi-Wei Ai
SLShun-Xiang Li
Shun-Xiang Li
This review reveals that Morinda citrifolia L., with bioactive components, alleviates systemic metabolic disorders through multiple mechanisms, provides in vitro / in vivo evidence, and highlights its potential as a natural intervention for SMD.

1 January 2026 in Targetome
Verified
Journal Article
Open access
PDF file
YDYan Duan
Yan Duan
LLLiu-Ye Li
Liu-Ye Li
QLQin-Zhe Lou
Qin-Zhe Lou
YLYu-Yuan Liao
Yu-Yuan Liao
JLJuan Li
Juan Li
SLShunxiang Li
Shunxiang Li
Osteoporosis is a heterogeneous skeletal disorder arising from diverse age-related, endocrine, metabolic, mechanical, and pharmacological factors. In age-related, postmenopausal, and selected metabolism-associated forms of osteoporosis, immunosenescence may contribute to dysfunction in the bone marrow immune niche, thereby amplifying bone resorption and regenerative decline. This review examines osteoporosis through the complementary perspective of the bone marrow immune niche and summarizes the core mechanisms by which immunosenescence contributes to destabilization of the bone marrow immune niche in osteoporosis. On this basis, we further discuss the molecular basis and regulatory potential of natural products in mediating bone marrow-related immune microenvironmental reprogramming. Emerging technologies, including single-cell omics, spatial omics, organoid models, and humanized research platforms, are also integrated to propose novel strategies for the precision prevention and treatment of osteoporosis. Overall, this review incorporates immune microenvironmental regulation into the conventional framework of bone metabolic dysfunction and provides a systematic theoretical basis for mechanistic elucidation, precision delivery, and clinical translation of natural products in prevention and treatment of osteoporosis.

20 October 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
QLQinzhe Luo
Qinzhe Luo
ZLZhaoxing Li
Zhaoxing Li
YLYuyuan Liao
Yuyuan Liao
WCWenshuo Chen
Wenshuo Chen
ZXZhihong Xu
Zhihong Xu
SLShunxiang Li
Shunxiang Li
Vascular dementia (VaD) is a heterogeneous cognitive disorder associated with cerebrovascular pathology and persistent vascular dysfunction. Because effective disease-modifying therapies remain limited, natural products have attracted interest as potential interventions for the complex pathology of VaD. This review examines their effects from two complementary perspectives: neuroprotection and neural repair. Experimental studies indicate that natural products can influence several interconnected processes, including redox imbalance, neuroinflammation, cell survival, blood–brain barrier dysfunction, vascular remodeling, neurogenesis, and synaptic plasticity. However, the available evidence varies considerably among isolated compounds, botanical extracts, and herbal formulations. Some isolated compounds have been supported by relatively coherent relationships between molecular targets, tissue responses, and functional outcomes, whereas evidence from clinical studies remains much more limited. We therefore consider the current mechanistic evidence together with the major challenges in pharmacokinetics, quality control, and clinical translation.